Allen A. Fienberg is VP of Business Development at Intra-Cellular Therapies, Inc. (ITCI). They have made 1 open-market trade across 1 company since 2015, most recently 2015-09-09.
CIK 0001585666
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ITCI | 295,000 | $38.9M |
Shares reported on the most recent Form 4, priced at the 2015-09-11 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.